STOCK TITAN

Ati Physical Therapy Inc Stock Price, News & Analysis

ATIP OTC

Welcome to our dedicated page for Ati Physical Therapy news (Ticker: ATIP), a resource for investors and traders seeking the latest updates and insights on Ati Physical Therapy stock.

ATI Physical Therapy Inc. (ATIP) provides investors and industry observers with centralized access to official company announcements and market-relevant developments. This resource aggregates press releases, financial updates, and strategic initiatives from one of America's leading outpatient rehabilitation providers.

Visitors will find timely updates on clinical research advancements through ATI's Institute for Musculoskeletal Advancement (iMSKA), partnership announcements, and operational milestones across its nationwide network of clinics. The curated selection focuses on material developments in orthopedic care innovation, workforce expansion, and evidence-based treatment methodologies.

Key content categories include quarterly financial results, leadership updates, service expansion notices, and peer-reviewed research publications. All materials maintain compliance with financial disclosure regulations while emphasizing ATIP's commitment to musculoskeletal health innovation.

Bookmark this page for streamlined tracking of ATI Physical Therapy's progress in advancing rehabilitation services through clinical excellence and operational growth. Check regularly for authoritative updates directly affecting market understanding of ATIP's position in healthcare services.

Rhea-AI Summary

ATI Physical Therapy (ATIP) has successfully closed a $26 million financing through 8% second lien PIK convertible notes on March 3, 2025. The notes, issued to existing preferred equity holders, will mature on August 24, 2028 and carry an 8% annual interest rate, payable quarterly in-kind through additional notes by capitalizing the interest amount on the outstanding principal balance.

CEO Sharon Vitti described this financing as a important step in strengthening the company's financial foundation and enabling the execution of their strategic vision. The transaction details are available in the company's Current Report on Form 8-K filed with the SEC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.88%
Tags
none
-
Rhea-AI Summary

ATI Physical Therapy (ATIP) and Tufts University School of Medicine announced a groundbreaking collaboration to expand access to physical therapy education. The initiative responds to a projected 27% increase in demand for physical therapy services by 2030. Key features include:

- Scholarships for up to 45 ATI employees per academic year in TUSM's Doctor of Physical Therapy (DPT) programs
- Sponsorship for 20 employees in TUSM-DPT's 12-week ADEPT program
- Increased access to clinical rotations at ATI's 850+ outpatient clinics
- Development of residency and fellowship training programs
- Joint research initiatives between TUSM and ATI

The collaboration aims to create accessible pathways for aspiring physical therapists, particularly targeting first-generation college students and those from lower-income households, while establishing a sustainable pipeline of skilled professionals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.11%
Tags
none
-
Rhea-AI Summary

ATI Physical Therapy (OTCMKTS: ATIP) has announced the termination of its previously announced tender offer to purchase up to 1,650,000 shares of its Class A common stock at $2.85 per share. The termination occurred because the Minimum Condition, which required 1,565,000 shares to be validly tendered, was not met.

As a result of the termination, no shares will be purchased and no consideration will be paid for any tendered shares. The tender offer was originally announced on December 17, 2024, and stockholders seeking additional information can contact Innisfree M&A Incorporated.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-35.42%
Tags
none
Rhea-AI Summary

ATI Physical Therapy (ATIP) has announced a tender offer to purchase up to 1,650,000 shares of its Class A common stock at $2.85 per share, representing approximately 37.4% of outstanding shares. The offer price represents a 290% premium over the December 16, 2024 closing price of $0.73. The tender offer will be funded through new notes under the company's amended second lien PIK note purchase agreement.

The offer requires a minimum tender of 1,565,000 shares and will expire on January 15, 2025. Stockholders can tender all or part of their shares and will receive payment in cash, subject to proration if the offer is oversubscribed. The Board of Directors has unanimously recommended stockholders accept the offer.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
205.49%
Tags
none
-
Rhea-AI Summary

ATI Physical Therapy (NYSE: ATIP) announced that its Class A common stock will be delisted from the New York Stock Exchange after market close on December 3, 2024, due to failing to maintain the required $15 million average global market capitalization over 30 consecutive trading days. The company's stock will transition to trading on the OTC Pink® Market.

ATI is currently in discussions for interim financing to provide liquidity opportunities for stockholders. The company states this transition won't affect its business operations, partner relationships, employees, or SEC reporting obligations. Management expressed confidence in their strategic plan and ongoing investments in people and patient experiences.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-44.69%
Tags
none
-
Rhea-AI Summary

ATI Physical Therapy (ATIP) has achieved an 'Exceptional' rating from the Center for Medicare and Medicaid Services' (CMS) Merit-Based Incentive Payment System (MIPS) for the fifth consecutive year since the program's inception in 2019. The company leveraged its proprietary electronic medical record and Patient Outcomes Registry™, which contains over 10 million patient reported outcomes across 4 million patient episodes. This recognition makes providers eligible for CMS reimbursement rate bonuses, helping offset continuing rate reductions. ATI, the largest single-branded outpatient physical therapy provider in the U.S., operates 900 locations across 24 states, offering comprehensive physical therapy services including virtual and workplace safety solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.35%
Tags
none
Rhea-AI Summary

ATI Physical Therapy (NYSE: ATIP) reported Q3 2024 financial results with net revenue of $190.0 million, up 7.1% from Q3 2023. Net patient revenue increased 7.7% to $174.7 million. The company reported a net loss of $32.9 million and Adjusted EBITDA of $12.1 million, up 28.8% year-over-year. Visits per Day increased 6.1% to 24,860. For Q4 2024, ATI projects revenue between $182-192 million and Adjusted EBITDA of $9-14 million. The company noted its liquidity position requires additional capital to fund operations and meet near-term needs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-40.09%
Tags
-
Rhea-AI Summary

ATI Physical Therapy, Inc. (NYSE: ATIP), a leading outpatient physical therapy provider in the United States, has announced that it will release its third quarter 2024 financial results on Monday, November 4, 2024, after the market closes. The company will host a conference call to review the results at 5 p.m. ET on the same day.

Interested parties can access the live audio webcast of the conference call through the ATI Physical Therapy, Inc. Q3 2024 Earnings Conference Call link on the company's Investor Relations website at https://investors.atipt.com. Participants are advised to join at least 15 minutes early to register and download any necessary audio software. A replay of the call will be available for on-demand listening shortly after the completion of the call and will remain accessible for approximately 90 days.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.53%
Tags
-
Rhea-AI Summary

ATI Physical Therapy (NYSE: ATIP) reported strong growth in Q2 2024, with revenue increasing 9.2% to $188.1 million. Key highlights include:

- Patient visits up 6.4% to 24,921 per day
- Rate per Visit increased 3.4% to $108.32
- Adjusted EBITDA grew 77.5% to $16.6 million
- Net loss narrowed to $2.6 million from $21.7 million in Q2 2023

The company received an exceptional MIPS rating for the 5th consecutive year. For Q3 2024, ATI guides revenue between $180-$190 million and Adjusted EBITDA of $9-$14 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.75%
Tags
Rhea-AI Summary

ATI Physical Therapy (NYSE: ATIP), a leading outpatient physical therapy provider in the United States, has announced that it will release its second quarter 2024 financial results on Monday, August 5, 2024, after the market closes. The company will host a conference call to review the results at 5 p.m. ET on the same day.

Investors and interested parties can access the live audio webcast of the conference call through the ATI Physical Therapy, Inc. Q2 2024 Earnings Conference Call link on the company's Investor Relations website at https://investors.atipt.com. Participants are advised to join at least 15 minutes early to register and download any necessary audio software. A replay of the call will be available for on-demand listening shortly after the call's completion and will remain accessible for approximately 90 days.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.87%
Tags

FAQ

What is the current stock price of Ati Physical Therapy (ATIP)?

The current stock price of Ati Physical Therapy (ATIP) is $0.8525 as of May 1, 2025.

What is the market cap of Ati Physical Therapy (ATIP)?

The market cap of Ati Physical Therapy (ATIP) is approximately 10.9M.
Ati Physical Therapy Inc

OTC:ATIP

ATIP Rankings

ATIP Stock Data

10.95M
1.93M
2.77%
52.94%
1.06%
Medical Care Facilities
Services-nursing & Personal Care Facilities
Link
United States
BOILINGBROOK